319 related articles for article (PubMed ID: 28159677)
1. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
[TBL] [Abstract][Full Text] [Related]
2. A smooth muscle-derived, Braf-driven mouse model of gastrointestinal stromal tumor (GIST): evidence for an alternative GIST cell-of-origin.
Kondo J; Huh WJ; Franklin JL; Heinrich MC; Rubin BP; Coffey RJ
J Pathol; 2020 Dec; 252(4):441-450. PubMed ID: 32944951
[TBL] [Abstract][Full Text] [Related]
3. Molecular and clinicopathological features of KIT/PDGFRA wild-type gastrointestinal stromal tumors.
Nishida T; Naito Y; Takahashi T; Saito T; Hisamori S; Manaka D; Ogawa K; Hirota S; Ichikawa H
Cancer Sci; 2024 Mar; 115(3):894-904. PubMed ID: 38178783
[TBL] [Abstract][Full Text] [Related]
4. No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases.
Lasota J; Xi L; Coates T; Dennis R; Evbuomwan MO; Wang ZF; Raffeld M; Miettinen M
Mod Pathol; 2013 Nov; 26(11):1488-91. PubMed ID: 23702733
[TBL] [Abstract][Full Text] [Related]
5. Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study.
Rubió-Casadevall J; Borràs JL; Carmona-García MC; Ameijide A; Gonzalez-Vidal A; Ortiz MR; Bosch R; Riu F; Parada D; Martí E; Miró J; Sirvent JJ; Galceran J; Marcos-Gragera R
World J Surg Oncol; 2015 Feb; 13():47. PubMed ID: 25885906
[TBL] [Abstract][Full Text] [Related]
6. Tumor genotype, location, and malignant potential shape the immunogenicity of primary untreated gastrointestinal stromal tumors.
Gasparotto D; Sbaraglia M; Rossi S; Baldazzi D; Brenca M; Mondello A; Nardi F; Racanelli D; Cacciatore M; Dei Tos AP; Maestro R
JCI Insight; 2020 Nov; 5(22):. PubMed ID: 33048845
[TBL] [Abstract][Full Text] [Related]
7. Impact of KIT and PDGFRA gene mutations on prognosis of patients with gastrointestinal stromal tumors after complete primary tumor resection.
Hou YY; Grabellus F; Weber F; Zhou Y; Tan YS; Li J; Shen KT; Qin J; Sun YH; Qin XY; Bockhorn M; Gerken G; Broelsch CE; Frilling A
J Gastrointest Surg; 2009 Sep; 13(9):1583-92. PubMed ID: 19291337
[TBL] [Abstract][Full Text] [Related]
8. SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors.
Gaal J; Stratakis CA; Carney JA; Ball ER; Korpershoek E; Lodish MB; Levy I; Xekouki P; van Nederveen FH; den Bakker MA; O'Sullivan M; Dinjens WN; de Krijger RR
Mod Pathol; 2011 Jan; 24(1):147-51. PubMed ID: 20890271
[TBL] [Abstract][Full Text] [Related]
9. Fluorescent In Situ Hybridization Must be Preferred to pan-TRK Immunohistochemistry to Diagnose NTRK3-rearranged Gastrointestinal Stromal Tumors (GIST).
Castillon M; Kammerer-Jacquet SF; Cariou M; Costa S; Conq G; Samaison L; Douet-Guilbert N; Marcorelles P; Doucet L; Uguen A
Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):626-634. PubMed ID: 33758144
[TBL] [Abstract][Full Text] [Related]
10. KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors.
Palomba G; Paliogiannis P; Sini MC; Colombino M; Casula M; Manca A; Pisano M; Sotgiu G; Doneddu V; Palmieri G; Cossu A
Eur J Cancer Prev; 2021 Jan; 30(1):53-58. PubMed ID: 32091431
[TBL] [Abstract][Full Text] [Related]
11. Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age.
Miettinen M; Wang ZF; Sarlomo-Rikala M; Osuch C; Rutkowski P; Lasota J
Am J Surg Pathol; 2011 Nov; 35(11):1712-21. PubMed ID: 21997692
[TBL] [Abstract][Full Text] [Related]
12. Morphological Correlates of KIT and PDGFRA Genotypes in Gastrointestinal Stromal Tumour.
Priya V; Kumari N; Krishnani N
Turk Patoloji Derg; 2020; 36(2):116-125. PubMed ID: 31538651
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal stromal tumors: A multidisciplinary challenge.
Sanchez-Hidalgo JM; Duran-Martinez M; Molero-Payan R; Rufian-Peña S; Arjona-Sanchez A; Casado-Adam A; Cosano-Alvarez A; Briceño-Delgado J
World J Gastroenterol; 2018 May; 24(18):1925-1941. PubMed ID: 29760538
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation status of known methylation-sensitive CpG islands in gastrointestinal stromal tumors without any correlation to the state of c-kit and PDGFRA gene mutations and their malignancy.
Saito K; Sakurai S; Sano T; Sakamoto K; Asao T; Hosoya Y; Nakajima T; Kuwano H
Cancer Sci; 2008 Feb; 99(2):253-9. PubMed ID: 18271923
[TBL] [Abstract][Full Text] [Related]
15. KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study.
Incorvaia L; De Biase D; Nannini M; Fumagalli E; Vincenzi B; De Luca I; Brando C; Perez A; Pantaleo MA; Gasperoni S; D'Ambrosio L; Grignani G; Maloberti T; Pedone E; Bazan Russo TD; Mazzocca A; Algeri L; Dimino A; Barraco N; Serino R; Gristina V; Galvano A; Bazan V; Russo A; Badalamenti G
Oncologist; 2024 Jan; 29(1):e141-e151. PubMed ID: 37463014
[TBL] [Abstract][Full Text] [Related]
16. Gene mutations and prognostic factors analysis in extragastrointestinal stromal tumor of a Chinese three-center study.
Zheng S; Huang KE; Tao DY; Pan YL
J Gastrointest Surg; 2011 Apr; 15(4):675-81. PubMed ID: 21274753
[TBL] [Abstract][Full Text] [Related]
17. Morphological, immunohistochemical, and genetic analyses of epithelioid gastrointestinal stromal tumors.
Shi J; Sun K; Kong F; Shen D
Ann Diagn Pathol; 2023 Dec; 67():152208. PubMed ID: 37696133
[TBL] [Abstract][Full Text] [Related]
18. VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer.
Schafroth C; Galván JA; Centeno I; Koelzer VH; Dawson HE; Sokol L; Rieger G; Berger MD; Hädrich M; Rosenberg R; Nitsche U; Schnüriger B; Langer R; Inderbitzin D; Lugli A; Zlobec I
Oncotarget; 2015 Dec; 6(39):41453-63. PubMed ID: 26496026
[TBL] [Abstract][Full Text] [Related]
19.
Machado I; Claramunt-Alonso R; Lavernia J; Romero I; Barrios M; Safont MJ; Santonja N; Navarro L; López-Guerrero JA; Llombart-Bosch A
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612518
[TBL] [Abstract][Full Text] [Related]
20. Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous
Bauer S; Heinrich MC; George S; Zalcberg JR; Serrano C; Gelderblom H; Jones RL; Attia S; D'Amato G; Chi P; Reichardt P; Meade J; Su Y; Ruiz-Soto R; Blay JY; von Mehren M; Schöffski P
Clin Cancer Res; 2021 Dec; 27(23):6333-6342. PubMed ID: 34503977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
